Bank Vontobel AG Share Price

Certificat

RJNAAV

CH1275375504

Market Closed - Swiss Exchange 08:50:00 03/06/2024 pm IST
99.9 USD +0.10% Intraday chart for Bank Vontobel AG
6 months+1.11%
Current year+0.60%
Date Price Change
03/24/03 99.9 +0.10%

Delayed Quote Swiss Exchange

Last update June 03, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Vontobel Vontobel
RJNAAV
ISINCH1275375504
Date issued 27/07/2023
Strike 173.5 $
Maturity 29/07/2024 (56 Days)
Parity 0.17 : 1
Emission price 100 $
Emission volume N/A
Settlement both
Currency USD

Technical Indicators

Highest since issue 100.4 $
Lowest since issue 95.5 $
Spread 3 $
Spread %0.30%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.7 USD
Average target price
171.9 USD
Spread / Average Target
+17.23%
Consensus
  1. Stock Market
  2. Certificates
  3. RJNAAV Certificat